Afferent fiber-selective shift in opiate potency following targeted opioid receptor knockdown

Author： Jones T.L.   Sweitzer S.M.   Wilson S.P.   Yeomans D.C.  

Publisher： Elsevier

ISSN： 0304-3959

Source： Pain, Vol.106, Iss.3, 2003-12, pp. : 365-371

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Selective osteopontin knockdown exerts anti‐tumoral activity in a human glioblastoma model

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 126, Iss. 8, 2010-04 ,pp. : 1797-1805

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selective TBK1/IKKi dual inhibitors with anticancer potency

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 134, Iss. 8, 2014-04 ,pp. : 1972-1980

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selective estrogen receptor modulators

By Petersen Nicole   Briggs Amber  

Clinical Review in Bone and Mineral Metabolism, Vol. 3, Iss. 1, 2005-03 ,pp. : 19-30

Humana Press, Inc

Access to resources Recommend Favorite

The mu opioid receptor: A new target for cancer therapy?

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2681-2688

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mutations in the opioid growth factor receptor in human cancers alter receptor function

By      

International Journal of Molecular Medicine, Vol. 36, Iss. 1, 2015-01 ,pp. : 289-293

Spandidos Publications

Access to resources Recommend Favorite